This podcast explores the evolving landscape of GLP-1 therapies, highlighting new formulations, emerging clinical uses and future directions of metabolic care. The episode reviews access and affordability while also providing a clear understanding of where GLP-1 therapy is headed in this rapidly changing field.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.